This publication is from the Transforming the Evaluation of Agrochemicals (TEA) Committee.
Transforming the Evaluation of Agrochemicals: A Conceptual Model
Regulatory Toxicology and Pharmacology, 2025
Open access, peer-reviewed publications ensure that knowledge is a public good. HESI believes that accessible research is critical for equitable engagement, diverse collaboration, and increased interdisciplinary conversation. We strive to achieve open access on all publications, and more than 200 publications from HESI programs have been published in the last decade.
Regulatory Toxicology and Pharmacology, 2025
This publication is from the Transforming the Evaluation of Agrochemicals (TEA) Committee.
2025
HESI Global'sĀ Developmental and Reproductive Toxicology (DART) CommitteeĀ held a multi-stakeholder workshop in Fall 2023 to address strategies to improve developmental and reproductive toxicity assessments for oligonucleotide (ONT) therapeutics, aiming to support the development of internationally harmonized ...
Nature Immunology, 2025
The meeting report from the Fall 2024 workshop co-hosted by the National Institute of Allergy and Infectious Diseases (NIAID) and the Health and Environmental Sciences Institute (HESI) on Regulatory T Cell (Treg) Therapies for Autoimmune Diseases and Transplant Rejection has been published in Nature Immunology.
Environmental Toxicology and Chemistry, 2025
The HESI GlobalĀ Next Generation Ecological Risk Assessment CommitteeĀ is proud to share a new publication in collaboration with the UK's NC3Rs: āEvaluation of in vivo fish and amphibian endocrine test guideline assays: current status and future needsā (Environmental Toxicology and Chemistry, Burden et al., ...
Toxicology and Applied Pharmacology, 2025
TheĀ Botanical Safety ConsortiumĀ has a new publication that demonstrates how computational modeling can streamline safety evaluations of botanical products.
Regulatory Toxicology and Pharmacology, 2025
This study addresses a critical public health and regulatory issue: how to effectively detect and assess the mutagenic and carcinogenic risks posed by nitrosamine impurities in medications.
hesi@hesiglobal.org
Phone: +1-202-659-8404
Fax: +1-202-659-8403
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.